CClinicalTrials.gg
CompletedNCT04451161Updated Sep 12, 2025Results posted

A Hybrid Type 2 Trial of Trauma-Focused Cognitive Behavioral Therapy and a Pragmatic Individual-Level Implementation Strategy

An interventional study of Beliefs and Attitudes for Successful Implementation in Schools (BASIS) and Trauma-Focused Cognitive-Behavioral Therapy in Evidence-Based Practices, CBT and School Health Services, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 7 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-12.

Sponsored by University of Washington · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
292
Allocation
Randomized
Ages
7 Years to 85 Years
Sex
All
01

Study summary

This research project is a hybrid type 2 effectiveness-implementation trial that simultaneously examines (1) the effectiveness of a trauma-focused intervention for youth in the education sector and (2) the impact of a theory-driven pragmatic implementation strategy designed to increase the adoption, fidelity, and sustainment of evidence-based treatments (EBTs). This trial will include 120 clinicians and 480 students, and it is designed to test the cost effectiveness and impact of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) in a new setting that increases access to mental health care - schools (Aim 1); test the cost effectiveness, immediate impact, and sustained impact of the Beliefs and Attitudes for Successful Implementation in Schools (BASIS) implementation strategy on proximal mechanisms and implementation outcomes (Aims 2a, 2b, 2d); and conduct sequential mixed-methods data collection to explain residuals (i.e., clinicians whose implementation behavior is unaccounted for by the mediation model) (Aim 2c).

02

Conditions studied

  • Evidence-Based Practices
  • CBT
  • School Health Services
  • Trauma, Psychological

Browse trials for

03

In context

Psychological Trauma

139 studies on the registry are indexed under Psychological Trauma; 41 are open to participants now.

This study's enrollment of 292 is above the median of 80 across 105 interventional studies indexed under Psychological Trauma.

Browse Psychological Trauma studies →

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Clinicians will be included if they (a) provide school-based services in a participating district; (b) have not previously received formal training in TF-CBT; and (c) are not actively receiving support to implement another trauma-focused intervention.

Students subjects will meet TF-CBT eligibility criteria, including (a) be within the TF-CBT developmental range (ages 8 to 19), (b) have traumatic event exposure (e.g., exposure to violence), and (c) significant post-traumatic stress symptoms.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
292 participants (actual)

Study arms

  • Other
    BASIS with TF-CBT

    Implementation intervention: experimental arm (Beliefs and Attitudes for Successful Implementation in Schools) Clinical Intervention: experimental arm (Trauma-Focused CBT)

    Behavioral: Beliefs and Attitudes for Successful Implementation in Schools (BASIS) · Behavioral: Trauma-Focused Cognitive-Behavioral Therapy

  • Other
    Attention Control (AC) with TF-CBT

    Implementation intervention: control arm Clinical Intervention: experimental arm (Trauma-Focused CBT)

    Behavioral: Trauma-Focused Cognitive-Behavioral Therapy · Behavioral: Attention Control

  • Other
    Enhanced Treatment as Usual

    Implementation intervention: non-applicable Clinical Intervention: control arm (Enhanced TAU)

    Behavioral: Treatment as Usual

Interventions

  • BehavioralBeliefs and Attitudes for Successful Implementation in Schools (BASIS)

    BASIS blended (i.e., multifaceted and protocolized) implementation strategy, which occurs at the beginning of active implementation. BASIS is designed to facilitate observable implementation outcomes, including EBP adoption and intervention fidelity, via strategic education, motivational Interviewing, and social influence strategies.

  • BehavioralTrauma-Focused Cognitive-Behavioral Therapy

    TF-CBT is an evidence-based treatment that helps children from elementary to high school to address the negative effects of trauma and promote greater emotion and behavior regulation, including processing their traumatic memories, overcoming problematic thoughts and behaviors, and developing effective coping and interpersonal skills. It also includes a treatment component for parents or other caregivers. Parents can learn skills related to stress management, positive parenting, behavior management, and effective communication.

  • BehavioralTreatment as Usual

    Scaffolded intervention as usual. Includes: initial assessment of trauma symptoms, psychoeducation, follow-up planning and support.

  • BehavioralAttention Control

    Didactic presentation of implementation-related content (e.g., information about the importance of implementing, definitions of key terms, etc.) to control for facilitator, dose, information provided, and delivery platform

06

What researchers measure

Primary outcomes

  1. TF-CBT Adoption and Penetration

    Participants provided data every 2-3 months for up to two years, reporting: How many students received CPSS-V (PTSD screener)? With how many students was TF-CBT initiated? With how many students was it completed? This allowed for monitoring of both reach (screening) and implementation (initiation/completion) of TF-CBT.

    Time frame: 18 Months- Active phase (timepoint 6 to 9); Sustainment phase (timepoint 10 to 12)

  2. Child PTSD Symptom Scale for DSM-V

    The Child PTSD Symptom Scale Self-Report for DSM-5 (CPSS-V) is a modified version of the original CPSS-SR adapted for DSM-5 criteria. The scale includes 20 PTSD symptom items scored on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("6 or more times a week / severe"), where higher scores indicate greater symptom severity. The scale includes 7 functioning items rated as "yes" or "no." The total score ranges from 0 to 80, with higher scores reflecting worse PTSD symptom severity.

    Time frame: 6 Months - Baseline (T1); 3-month follow up (T2); 6-month follow up (T3)

  3. Mood and Feelings Questionnaire - Short

    The Short Mood and Feelings Questionnaire (SMFQ) is a 13-item self-report measure assessing recent emotional and behavioral states. It consists of descriptive phrases rated based on how often they applied to the subject over the past two weeks: 0 ("not at all"), 1 ("sometimes"), or 2 ("most of the time"). The total score ranges from 0 to 26, with higher scores indicating greater severity of depressive symptoms (worse outcome).

    Time frame: 6 Months - Baseline (T1); 3-month follow up (T2); 6-month follow up (T3)

07

Results

Posted Jul 15, 2025

Participant flow

School districts across the United States were recruited to participate in the study, where the district leaders provided a list of potential eligible clinicians currently employed in schools in the district. The eligibility criteria for clinicians were a) provided school-based services for the participating school district; b) did not receive formal training in TF-CBT or CBT+; c) did not receive support to implement another trauma-focused intervention.

Participant flow — Overall Study
MilestoneBASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)
Started626564343235
End of training period (provider)474554000
End of active phase of the study (provider)373048000
3-month follow up (student)000262421
Completed312842211917
Not completed313722131318
Withdrew: Lost to follow-up283722131114
Withdrew: Withdrawal by subject300024

Outcome measures

PrimaryTF-CBT Adoption and Penetration

Participants provided data every 2-3 months for up to two years, reporting: How many students received CPSS-V (PTSD screener)? With how many students was TF-CBT initiated? With how many students was it completed? This allowed for monitoring of both reach (screening) and implementation (initiation/completion) of TF-CBT.

Time frame:
18 Months- Active phase (timepoint 6 to 9); Sustainment phase (timepoint 10 to 12)
Reported as:
Count of participants · Participants
TF-CBT Adoption and Penetration
ParticipantsBASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)
Administered CPSS-V with at least one student.332633
Started TF-CBT with at least one student.312621
Completed TF-CBT with at least one student.111219
Statistical analysis
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.591 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants administered the CPSS-V to at least one student beginning of the active phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.032 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants administered the CPSS-V to at least one student by the end of the active phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.054 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants administered the CPSS-V to at least one student by the end of the sustainment phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.98 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants started TF-CBT with at least one student at the beginning of the active phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.068 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants started TF-CBT with at least one student by the end of the active phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.165 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants started TF-CBT with at least one student by the end of the sustainment phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.191 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants completed TF-CBT with at least one student by the end of the active phase.)
  • BASIS With TF-CBT (Provider) vs AC (Attention Control) With TF-CBT (Provider) · Chi-squared · p = 0.86 (We performed a chi-squared analysis comparing the study groups (BASIS vs. Attention Control) on whether participants completed TF-CBT with at least one student at the end of the sustainment phase.)
PrimaryChild PTSD Symptom Scale for DSM-V

The Child PTSD Symptom Scale Self-Report for DSM-5 (CPSS-V) is a modified version of the original CPSS-SR adapted for DSM-5 criteria. The scale includes 20 PTSD symptom items scored on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("6 or more times a week / severe"), where higher scores indicate greater symptom severity. The scale includes 7 functioning items rated as "yes" or "no." The total score ranges from 0 to 80, with higher scores reflecting worse PTSD symptom severity.

Time frame:
6 Months - Baseline (T1); 3-month follow up (T2); 6-month follow up (T3)
Reported as:
Mean · Score on a scale
Child PTSD Symptom Scale for DSM-V
Score on a scaleBASIS With TF-CBT (Student)Attention Control With TF-CBT (Student)Enhanced Treatment as Usual (Student)
Baseline (T1)34.7 ± 15.939.3 ± 18.737.1 ± 16.1
3-month follow up (T2)28.3 ± 16.234.4 ± 16.228.1 ± 17.4
6-month follow up (T3)26.1 ± 17.732.2 ± 18.819.4 ± 16.3
Statistical analysis
  • BASIS With TF-CBT (Student) vs Enhanced Treatment as Usual (Student) · Mixed Models Analysis · p = 0.22 (Mixed model analysis was used (students were clustered under the providers who recruited them) to understand if BASIS+TF-CBT has a greater effect on decreasing trauma PTSD symptoms (measured using CPSS-V) over time.) · Slope: 3.425 · 95% CI -2.064 to 8.915
  • Attention Control With TF-CBT (Student) vs Enhanced Treatment as Usual (Student) · Mixed Models Analysis · p = 0.075 (Mixed model analysis was used (the students were clustered under the providers who recruited them) to understand if AC+TF-CBT has a greater effect on decreasing trauma PTSD symptoms (measured using CPSS-V) over time.) · Slope: 4.97 · 95% CI -.502 to 10.443
PrimaryMood and Feelings Questionnaire - Short

The Short Mood and Feelings Questionnaire (SMFQ) is a 13-item self-report measure assessing recent emotional and behavioral states. It consists of descriptive phrases rated based on how often they applied to the subject over the past two weeks: 0 ("not at all"), 1 ("sometimes"), or 2 ("most of the time"). The total score ranges from 0 to 26, with higher scores indicating greater severity of depressive symptoms (worse outcome).

Time frame:
6 Months - Baseline (T1); 3-month follow up (T2); 6-month follow up (T3)
Reported as:
Mean · score on a scale
Mood and Feelings Questionnaire - Short
score on a scaleBASIS With TF-CBT (Student)Attention Control With TF-CBT (Student)Enhanced Treatment as Usual (Student)
Baseline (T1)10.3 ± 7.711.7 ± 7.110.7 ± 5.9
3-month follow up (T2)7.7 ± 4.812.1 ± 6.37.2 ± 4.4
6-month follow-up (T3)6.8 ± 6.310 ± 7.34.9 ± 4.3
Statistical analysis
  • BASIS With TF-CBT (Student) vs Enhanced Treatment as Usual (Student) · Mixed Models Analysis · p = 0.284 (Mixed model analysis was used (students were clustered under the providers who recruited them) to understand if BASIS+TF-CBT has a greater effect on decreasing negative mood and feelings symptoms (measured using SMFQ) over time.) · Slope: 1.024 · 95% CI -.855 to 2.904
  • Attention Control With TF-CBT (Student) vs Enhanced Treatment as Usual (Student) · Mixed Models Analysis · p = .046 (Mixed model analysis was used (students were clustered under the providers who recruited them) to understand if AC+TF-CBT has a greater effect on decreasing negative mood and feelings symptoms (measured using SMFQ) over time.) · Slope: 1.908 · 95% CI .03 to 3.786

Adverse events

Collected over 6 months- Baseline (T1), 3-month follow up (T2), 6-month follow up (T3). Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
BASIS With TF-CBT (Student)0/34 (0%)0/34 (0%)3/34 (8.8%)
Attention Control With TF-CBT (Student)0/32 (0%)0/32 (0%)4/32 (12.5%)
Enhanced Treatment as Usual (Student)0/35 (0%)0/35 (0%)2/35 (5.7%)
BASIS With TF-CBT (Provider)———
AC (Attention Control) With TF-CBT (Provider)———
Enhanced Treatment as Usual (Provider)———
Most frequent other events
Most frequent other events
EventBASIS With TF-CBT (Student)Attention Control With TF-CBT (Student)Enhanced Treatment as Usual (Student)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)
Suicidal Ideation/ Self-harmSocial circumstances3/344/322/35———

Baseline characteristics

The eligibility criteria for clinicians: a) provided school-based services for the participating school district; b) did not receive formal training in TF-CBT or CBT+; c) did not receive support to implement another trauma-focused intervention. Eligible students recruited by participating providers: a) within the TF-CBT development age ( 8-19); b) experienced a traumatic event exposure (e.g., exposure to violence); and c) significant post-traumatic stress symptoms.

Age, Categorical
Age, Categorical(Participants)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)Total
<=18 years000343235101
Between 18 and 65 years626463000189
>=65 years0110002
Age, Continuous
Age, Continuous(Years)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)Total
Mean———11 ± 2.712 ± 3.211.2 ± 2.511.4 ± 2.8
Sex/Gender, Customized
Sex/Gender, Customized(Participants)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)Total
Female585860161417223
Male26418121658
Transgender0000213
Non-binary2000215
Unknown or not reported0100203
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)Total
Hispanic or Latino321103120
Not Hispanic or Latino596363242834271
Unknown or Not Reported0000101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)Total
American Indian or Alaska Native0001012
Asian1141007
Native Hawaiian or Other Pacific Islander0102014
Black or African American22302211
White555555141723219
More than one race221138531
Unknown or Not Reported24135318
Region of Enrollment
Region of Enrollment(Participants)BASIS With TF-CBT (Provider)AC (Attention Control) With TF-CBT (Provider)Enhanced Treatment as Usual (Provider)BASIS With TF-CBT (Students)AC (Attention Control) With TF-CBT (Student)Enhanced Treatment as Usual (Student)Total
United States626564343235292
08

Study locations

1 site
  • University of Washington
    Seattle, Washington 98115, United States
09

References and documents

Publications

  • Lyon AR, Pullmann MD, Dorsey S, Levin C, Gaias LM, Brewer SK, Larson M, Corbin CM, Davis C, Muse I, Joshi M, Reyes R, Jungbluth NJ, Barrett R, Hong D, Gomez MD, Cook CR. Protocol for a hybrid type 2 cluster randomized trial of trauma-focused cognitive behavioral therapy and a pragmatic individual-level implementation strategy. Implement Sci. 2021 Jan 7;16(1):3. doi: 10.1186/s13012-020-01064-1. PubMed 33413511 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 5, 2025
  • Informed consent form · Sep 21, 2021

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04451161
Lead sponsor
University of Washington
Collaborators
National Institute of Mental Health (NIMH), University of Minnesota
Responsible party
Aaron Lyon (Associate Professor, School of Medicine: Psychiatry: Childrens Division, University of Washington) — Principal investigator
First posted
Jun 30, 2020
Start date
Aug 27, 2020
Primary completion
Jun 1, 2024
Completion
Jun 30, 2024
Results posted
Jul 15, 2025
Last update
Sep 12, 2025

Study contacts

Aaron Lyon, PhD
principal investigator · University of Washington

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion